Todd M. Gross

2.4k total citations
43 papers, 1.8k citations indexed

About

Todd M. Gross is a scholar working on Neurology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Todd M. Gross has authored 43 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Neurology, 16 papers in Surgery and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Todd M. Gross's work include Botulinum Toxin and Related Neurological Disorders (24 papers), Diabetes Management and Research (11 papers) and Neurological disorders and treatments (9 papers). Todd M. Gross is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (24 papers), Diabetes Management and Research (11 papers) and Neurological disorders and treatments (9 papers). Todd M. Gross collaborates with scholars based in United States, Canada and Austria. Todd M. Gross's co-authors include John J. Mastrototaro, Bruce W. Bode, Murray E. Jarvik, Martin R. Rosenblatt, David Kayne, Neil H. White, John H. Reed, Daniel Einhorn, Paul F. Lizzul and Frederick C. Beddingfield and has published in prestigious journals such as Neurology, American Journal of Public Health and Psychopharmacology.

In The Last Decade

Todd M. Gross

38 papers receiving 1.6k citations

Peers

Todd M. Gross
Miguel Debono United Kingdom
Antonio Gangemi United States
Brian D. Cohen United States
Ling Leng China
Todd M. Gross
Citations per year, relative to Todd M. Gross Todd M. Gross (= 1×) peers Kazuhito Fukuda

Countries citing papers authored by Todd M. Gross

Since Specialization
Citations

This map shows the geographic impact of Todd M. Gross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd M. Gross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd M. Gross more than expected).

Fields of papers citing papers by Todd M. Gross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd M. Gross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd M. Gross. The network helps show where Todd M. Gross may publish in the future.

Co-authorship network of co-authors of Todd M. Gross

This figure shows the co-authorship network connecting the top 25 collaborators of Todd M. Gross. A scholar is included among the top collaborators of Todd M. Gross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd M. Gross. Todd M. Gross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McAllister, Peter, Atul T. Patel, Aaron Ellenbogen, et al.. (2025). Long‐Term Safety and Efficacy of Repeat Treatments with DaxibotulinumtoxinA in Cervical Dystonia: Results from the ASPEN ‐Open‐Label Study. Movement Disorders Clinical Practice. 12(11). 1764–1773.
2.
Ellenbogen, Aaron, Robert A. Hauser, Atul T. Patel, et al.. (2025). Efficacy Remaining at Time of Requested Re-Treatment for Cervical Dystonia: A Potential New Treatment Paradigm with DaxibotulinumtoxinA. Toxins. 17(3). 133–133.
3.
Mariwalla, Kavita, Ava Shamban, Jeremy B. Green, et al.. (2024). Clinical Benefits of DaxibotulinumtoxinA for Injection: Beyond Glabellar Line Effacement?. Dermatologic Surgery. 50(9S). S18–S23.
8.
Jankovic, Joseph, Cynthia Comella, Robert A. Hauser, et al.. (2022). A Phase 3 Trial Evaluating the Efficacy, Duration of Effect, and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Cervical Dystonia (P1-1.Virtual). Neurology. 98(18_supplement). 1 indexed citations
9.
Dover, Jeffrey S., Shannon Humphrey, Z. Paul Lorenc, et al.. (2022). Treatment of Upper Facial Lines With DaxibotulinumtoxinA for Injection: Results From an Open-Label Phase 2 Study. Dermatologic Surgery. 49(1). 60–65. 3 indexed citations
10.
Solish, Nowell, Jean Carruthers, Joely Kaufman, et al.. (2021). Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A. Drugs. 81(18). 2091–2101. 49 indexed citations
11.
Jankovic, Joseph, Cynthia Comella, Robert A. Hauser, et al.. (2021). A Phase 3 Trial Evaluating the Efficacy, Duration of Effect, and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Cervical Dystonia (1478). Neurology. 96(15_supplement). 2 indexed citations
12.
Humphrey, Shannon, Jonathan M. Sykes, Jonathan Kantor, et al.. (2016). ATX-101 for reduction of submental fat: A phase III randomized controlled trial. Journal of the American Academy of Dermatology. 75(4). 788–797.e7. 86 indexed citations
13.
Dover, Jeffrey S., Jeffrey M. Kenkel, Alastair Carruthers, et al.. (2016). Management of Patient Experience With ATX-101 (Deoxycholic Acid Injection) for Reduction of Submental Fat. Dermatologic Surgery. 42(1). S288–S299. 25 indexed citations
14.
Tanenberg, Robert J., Bruce W. Bode, Wendy Lane, et al.. (2004). Use of the Continuous Glucose Monitoring System to Guide Therapy in Patients With Insulin-Treated Diabetes: A Randomized Controlled Trial. Mayo Clinic Proceedings. 79(12). 1521–1526. 103 indexed citations
15.
Heptulla, Rubina A., Holley F. Allen, Todd M. Gross, & Edward O. Reiter. (2004). Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy. Pediatric Diabetes. 5(1). 10–15. 25 indexed citations
16.
Bode, Bruce W., et al.. (2002). Diabetes management in the new millennium using insulin pump therapy. Diabetes/Metabolism Research and Reviews. 18(S1). S14–S20. 128 indexed citations
17.
Bode, Bruce W., et al.. (1999). Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Research and Clinical Practice. 46(3). 183–190. 184 indexed citations
18.
Jarvik, Murray E., et al.. (1995). Enhanced lexical processing of smoking stimuli during smoking abstinence. Psychopharmacology. 118(2). 136–141. 14 indexed citations
19.
McCarthy, William J., Nicholas H. Caskey, Murray E. Jarvik, et al.. (1995). Menthol vs nonmenthol cigarettes: effects on smoking behavior.. American Journal of Public Health. 85(1). 67–72. 72 indexed citations
20.
Caskey, Nicholas H., Murray E. Jarvik, William J. McCarthy, et al.. (1993). Rapid smoking of menthol and nonmenthol cigarettes by black and white smokers. Pharmacology Biochemistry and Behavior. 46(2). 259–263. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026